Published in
Wiley, Diabetes, Obesity and Metabolism, 10(20), p. 2399-2407, 2018
DOI: 10.1111/dom.13393
Links
Tools
Short- and long-term administration of the non-steroidal mineralocorticoid receptor antagonist finerenone opposes metabolic syndrome-related cardio-renal dysfunction
Journal article published in 2018 by
Marianne Lachaux,
Jonatan Barrera-Chimal,
Lionel Nicol,
Isabelle Rémy-Jouet,
Sylvanie Renet,
Anais Dumesnil,
Didier Wecker,
Vincent Richard,
Peter Kolkhof,
Frederic Jaisser,
Antoine Ouvrard-Pascaud,
Paul Mulder 
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 